Table 5. Adjusted HR estimates for SphK1 expression and recurrence of colon cancer-specific using multivariate Cox regression analysis.
Multivariate analysis |
|||
---|---|---|---|
Variables | Adjusted SHR | 95% CI | P value |
SphK1 expression | |||
Absence (Ref) | 1.0 | — | — |
Presence | 1.35 | 0.48–3.77 | 0.564 |
Age | |||
≤65 years (Ref) | 1.0 | — | — |
>65 years | 1.33 | 0.73–2.42 | 0.344 |
Ethnicity | |||
Chinese (Ref) | 1.0 | — | — |
Malays | 3.29 | 1.35–8.02 | 0.009 |
Indians | 2.17 | 0.45–10.50 | 0.336 |
Others | 0.86 | 0.14–5.23 | 0.873 |
Pre-op CEA levels | 1.002 | 1.00–1.001 | 0.647 |
AJCC stage | |||
Stages 1 and 2 (Ref) | 1.0 | — | — |
Stages 3 and 4 | 2.28 | 1.22–4.29 | 0.01 |
Vascular invasion | |||
Absence (Ref) | 1.0 | — | — |
Presence | 1.52 | 0.55–4.23 | 0.422 |
CEA, carcinoembryonic antigen; CI, confidence interval; HR, hazard ratio; SHR, sub-hazard ratio; SphK1, sphingosine kinase 1.